• Publications
  • Influence
ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE 2008
Authors/Task Force Members: Kenneth Dickstein (Chairperson) (Norway)*, Alain Cohen-Solal (France), Gerasimos Filippatos (Greece), John J.V. McMurray (UK), Piotr Ponikowski (Poland), Philip AlexanderExpand
  • 2,727
  • 186
  • PDF
Identification of seven loci affecting mean telomere length and their association with disease
Interindividual variation in mean leukocyte telomere length (LTL) is associated with cancer and several age-associated diseases. We report here a genome-wide meta-analysis of 37,684 individuals withExpand
  • 648
  • 47
  • PDF
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology
Peripartum cardiomyopathy (PPCM) is a cause of pregnancy‐associated heart failure. It typically develops during the last month of, and up to 6 months after, pregnancy in women without knownExpand
  • 636
  • 44
  • PDF
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡
Authors/Task Force Members: Kenneth Dickstein (Chairperson) (Norway)*, Alain Cohen-Solal (France), Gerasimos Filippatos (Greece), John J.V. McMurray (UK), Piotr Ponikowski (Poland), Philip AlexanderExpand
  • 1,466
  • 34
ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE 2008 (ENDING)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (ending).
  • 965
  • 34
Seventy-five genetic loci influencing the human red blood cell
Anaemia is a chief determinant of global ill health, contributing to cognitive impairment, growth retardation and impaired physical capacity. To understand further the genetic factors influencing redExpand
  • 332
  • 19
  • PDF
Non‐compliance in patients with heart failure; how can we manage it?
Because of the improvement of the pharmacological and non‐pharmacological treatment in heart failure (HF) patients, the HF related therapeutic regimen is becoming more complicated. Non‐complianceExpand
  • 319
  • 15
  • PDF
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and
Patients with acute heart failure (AHF) require urgent in‐hospital treatment for relief of symptoms. The main reason for hospitalization is congestion, rather than low cardiac output. AlthoughExpand
  • 466
  • 14
  • PDF
New gene functions in megakaryopoiesis and platelet formation
Platelets are the second most abundant cell type in blood and are essential for maintaining haemostasis. Their count and volume are tightly controlled within narrow physiological ranges, but there isExpand
  • 392
  • 13
  • PDF
Galectin‐3: a novel mediator of heart failure development and progression
Galectins are a family of soluble β‐galactoside‐binding lectins that play many important regulatory roles in inflammation, immunity, and cancer. Recently, a role for galectin‐3 in the pathophysiologyExpand
  • 402
  • 12
...
1
2
3
4
5
...